ONCR-177
UNII 83P3OQ67ZT
Substance Identification & Data
This profile provides standardized clinical and technical data for Oncr-177, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 83P3OQ67ZT.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
83P3OQ67ZT
N/A
N/A
Detailed Substance Profile
Preferred Name
ONCR-177
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Oncr-177. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
Common Names & Synonyms
HSV-1 MIR-ATTENUATED ONCOLYTIC ONCR-177
ONCR 177 [WHO-DD]
ONCR-177
ONCR-177, AN MIR-ATTENUATED ONCOLYTIC HSV-1 EXPRESSING ARMED WITH FIVE TRANSGENES (THE NK AND T CELL ACTIVATING CYTOKINE IL-12, THE CHEMOKINES CCL4 AND FLT3LG (EXTRACELLULAR DOMAIN) TO ALLOW FOR EXPANSION AND RECRUITMENT OF CLASSICAL DENDRITIC CELLS, AND ANTAGONISTS TO THE CLINICALLY VALIDATED IMMUNE CHECKPOINT TARGETS PD-1 AND CTLA-4)
